Tables S1-S3 from Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
Cécile Chartier(Io Therapeutics (United States)), Austin Gurney(Australian Centre for Heart Health), Wan-Ching Yen(OncoMed (United States)), Marcus Fischer(St. Jude Children's Research Hospital), Cristina Dee-Hoskins, Gilbert O’Young(OncoMed (United States)), Jennifer Cain(Gilead Sciences (United States)), Fumiko Axelrod(OncoMed (United States)), Belinda Cancilla(OncoMed (United States)), Pete Yeung(OncoMed (United States)), May Ji(OncoMed (United States)), Michelle Stroud, Ann M. Kapoun(OncoMed (United States)), Shirley Ma(University of Maryland Center for Environmental Science), Janak Raval, Timothy Hoey, Min Wang(Academy of Military Medical Sciences), Jalpa Shah(OncoMed (United States)), Jie Wei(Guangxi Medical University), Andrew Lam, Chris T. Bond(Neurosciences Institute), John Lewicki(OncoMed (United States))
Cited by 0
Related Papers
Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli
|Journal of Virology|1996|651
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
|Proceedings of the National Academy of Sciences|2012|630
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
|PLoS ONE|2008|582
Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma
|Journal of Clinical Oncology|2021|431